Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Phoenix, Arizona 85044


Purpose:

The purpose of this study is to determine the safety and efficacy of an ocular sirolimus (rapamycin) formulation via different injection routes in patients with treatment-naive sub-foveal choroidal neovascularization secondary to age-related macular degeneration.


Criteria:

Inclusion Criteria include, but are not limited to: - Diagnosed with sub-foveal choroidal neovascularization secondary to age-related macular degeneration - Visual acuity of 20/50 to 20/200 in study eye Exclusion Criteria: - Any other ocular disease that could compromise vision in the study eye - History of any prior treatment for choroidal neovascularization in the study eye - Presence of other causes of choroidal neovascularization other than secondary to age-related macular degeneration


NCT ID:

NCT00712491


Primary Contact:

Study Director
Joel Naor, MD
MacuSight, Inc.


Backup Contact:

N/A


Location Contact:

Phoenix, Arizona 85044
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.